tirzepatide study Lilly Decides to Advance for Obesity SUMMIT: Tirzepatide Improves Outcomes and

This is particularly important, considering that Pfizer (NYSE: PFE) recently discontinued its oral GLP-1 treatment because of these issues

8,9 In people with obesity diagnosed with T2DM for 6 years, 64% of those who achieved and maintained 10 kg WL with a low calorie diet were able to achieve T2DM remission at 2 years (Diabetes Remission Clinical Trial [DiRECT] study) and remission rates were higher the more the WL achieved

Importantly, participants were not seeking treatment for alcohol problems, meaning reductions in drinking occurred without explicit intention or behavioral therapy

[1] [2] It is important to note that while Ozempic is not licensed for weight loss in the UK, a different semaglutide product called Wegovy is specifically licensed for weight management

Try to incorporate weight lifting or body weight exercises into your workout routine at least 2-3 times per week to stimulate muscle growth and maintenance

Clinical trials (Phase 3)